DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,780,362 | +7.2% | 19,267 | +3.7% | 0.59% | +9.5% |
| Q2 2023 | $4,461,079 | -3.0% | 18,587 | +1.9% | 0.54% | -7.3% |
| Q1 2023 | $4,597,150 | -29.7% | 18,240 | -26.0% | 0.58% | -29.3% |
| Q4 2022 | $6,539,079 | +3.9% | 24,637 | +1.1% | 0.82% | -0.5% |
| Q3 2022 | $6,296,000 | +4.7% | 24,376 | +2.7% | 0.82% | +4.9% |
| Q2 2022 | $6,015,000 | -12.4% | 23,725 | +1.3% | 0.78% | +2.2% |
| Q1 2022 | $6,867,000 | -9.0% | 23,411 | +2.1% | 0.76% | -5.3% |
| Q4 2021 | $7,544,000 | +49.2% | 22,930 | +38.1% | 0.81% | +50.2% |
| Q3 2021 | $5,055,000 | +12.4% | 16,606 | -1.0% | 0.54% | +8.2% |
| Q2 2021 | $4,499,000 | +18.8% | 16,766 | -0.4% | 0.50% | +10.4% |
| Q1 2021 | $3,788,000 | +2.7% | 16,831 | +1.4% | 0.45% | -3.6% |
| Q4 2020 | $3,688,000 | +2.9% | 16,601 | -0.2% | 0.47% | -10.4% |
| Q3 2020 | $3,583,000 | +17.0% | 16,641 | -3.9% | 0.52% | +10.1% |
| Q2 2020 | $3,062,000 | +27.9% | 17,317 | +0.1% | 0.47% | +7.0% |
| Q1 2020 | $2,394,000 | -11.3% | 17,298 | -1.7% | 0.44% | +11.9% |
| Q4 2019 | $2,700,000 | +4.1% | 17,589 | -2.1% | 0.40% | -2.0% |
| Q3 2019 | $2,594,000 | +0.2% | 17,962 | -0.8% | 0.40% | +0.2% |
| Q2 2019 | $2,589,000 | +6.6% | 18,115 | -1.5% | 0.40% | +1.5% |
| Q1 2019 | $2,428,000 | +25.3% | 18,394 | -2.1% | 0.40% | +12.2% |
| Q4 2018 | $1,937,000 | -5.2% | 18,785 | -0.1% | 0.35% | -5.4% |
| Q3 2018 | $2,044,000 | +11.0% | 18,812 | +0.9% | 0.37% | +5.4% |
| Q2 2018 | $1,841,000 | -0.2% | 18,653 | -0.9% | 0.35% | -11.5% |
| Q1 2018 | $1,844,000 | +4.1% | 18,831 | -1.4% | 0.40% | +11.1% |
| Q4 2017 | $1,772,000 | +7.2% | 19,094 | -0.9% | 0.36% | +8.4% |
| Q3 2017 | $1,653,000 | +3.8% | 19,272 | +2.1% | 0.33% | -1.2% |
| Q2 2017 | $1,593,000 | -2.8% | 18,871 | -1.5% | 0.34% | -4.8% |
| Q1 2017 | $1,639,000 | +3.5% | 19,168 | -5.8% | 0.35% | 0.0% |
| Q4 2016 | $1,583,000 | -3.9% | 20,341 | -3.2% | 0.35% | -8.3% |
| Q3 2016 | $1,648,000 | -24.0% | 21,020 | -2.1% | 0.38% | -25.7% |
| Q2 2016 | $2,169,000 | +1.3% | 21,473 | -4.9% | 0.52% | 0.0% |
| Q1 2016 | $2,141,000 | -0.4% | 22,569 | -2.5% | 0.52% | -1.5% |
| Q4 2015 | $2,150,000 | +7.5% | 23,148 | -1.4% | 0.53% | +0.6% |
| Q3 2015 | $2,000,000 | +1.1% | 23,467 | +1.5% | 0.52% | +10.1% |
| Q2 2015 | $1,979,000 | +1.1% | 23,124 | +0.3% | 0.48% | +2.2% |
| Q1 2015 | $1,958,000 | -0.7% | 23,058 | +0.2% | 0.46% | -13.2% |
| Q4 2014 | $1,972,000 | +10.2% | 23,004 | -2.3% | 0.54% | +7.6% |
| Q3 2014 | $1,790,000 | -3.2% | 23,554 | +0.2% | 0.50% | -4.4% |
| Q2 2014 | $1,850,000 | +5.2% | 23,496 | +0.3% | 0.52% | -2.6% |
| Q1 2014 | $1,758,000 | -3.9% | 23,437 | -1.1% | 0.54% | -7.6% |
| Q4 2013 | $1,830,000 | +5.7% | 23,700 | -5.1% | 0.58% | -2.9% |
| Q3 2013 | $1,732,000 | +6.8% | 24,979 | -2.5% | 0.60% | -2.6% |
| Q2 2013 | $1,621,000 | – | 25,612 | – | 0.61% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |